Trial Identifier: | D3461R00087 |
Sponsor: | AstraZeneca |
Start Date: | March 2025 |
Primary Completion Date: | September 2026 |
Study Completion Date: | September 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.